Clinical Trials › NCT05797740
Active, Not Recruiting
Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)
Sponsored by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 367
Target enrollment
Aug 2023
Start date
Jan 2029
Expected completion
Interventions / Treatments
Mavenclad
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
The app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.